OOIR: Observatory of International Research

Papers

(The H4-Index of Lupus Science & Medicine is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort	218
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune disease	59
High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus	48
Genetic load in incomplete lupus erythematosus	47
B lymphocytes in treatment-naive paediatric patients with lupus are epigenetically distinct from healthy children	45
Differences in reproductive health discussions in an urban Hispanic population with SLE: lessons from the field	43
Evaluation and randomised controlled trial of home urinalysis testing in patients with SLE at elevated risk for developing lupus nephritis: a study protocol	39
Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus	37
Novel multiclass classification machine learning approach for the early-stage classification of systemic autoimmune rheumatic diseases	37
Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms	37
Towards a minimal core dataset for systemic lupus erythematosus studies	32
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE	31
Deucravacitinib, an oral, selective, allosteric, tyrosine kinase 2 inhibitor, in patients with active SLE: efficacy on patient-reported outcomes in a phase II randomised trial	28
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine	28
Langerhans cells infiltration in lymph nodes of patients with systemic lupus erythematosus	28
Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort	26
B cell polygenic risk scores associate with anti-dsDNA antibodies and nephritis in systemic lupus erythematosus	24
A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort	24
Mesenchymal stem cells improve ovarian function by suppressing fibrosis through CTGF/FAK signalling in systemic lupus erythematosus	23
VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory	23
Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials	22
Generation of evidence supporting the content validity of SF-36, FACIT-F, and LupusQoL, and novel patient-reported symptom items for use in patients with systemic lupus erythematosus (SLE) and SLE wit	21
Novel immunoprofiling method for diagnosing SLE and evaluating therapeutic response	21